This brings the list of currently effective pharmacological treatments to two:
- remedisivir (reduces hospital stay, might improve survival)
- dexamethasone (improves survival if requiring oxygen)
Edit: what's with the downvotes? Go look at my post history, I'm not some Russian astroturfing bot. And I got a lot of informative replies, which is why I asked in the first place.
it has known nontrivial side effects, but the study showing measurable harm was retracted.
https://www.theguardian.com/world/2020/jun/03/covid-19-surgi...
Others studies by one of the authors (Sapan Desai) whose company Surgisphere is supposed to be behind the alleged fraud are being scrutinised and even his credentials are under question now - https://www.theguardian.com/world/2020/jun/10/surgisphere-sa...
"These data convincingly rule out any meaningful mortality benefit of hydroxychloroquine in patients hospitalised with COVID-19."
Note this is not the same group or dataset as the discredited study.
See the discussion here[1] (from the person who wrote the open letter to Lancet on the now-retracted HCQ study).
[1] https://twitter.com/jwato_watson/status/1272734274823663616
But I wasn’t claiming they were doing so. I said “if” intentionally, since I know nothing about it.
I'm not expecting any different results than from this one, but we'll know soon enough.
The RECOVERY study is also studying azithromycin, a drug commonly administered with HCQ when used against this disease. It would be ironic if that one proves to be effective (study is still ongoing).
That study shows nothing. I assume there'll be others along in time.
[1] http://covexit.com/recovery-covid-19-research-blasted-for-to...
At a certain point, it's possibly worth considering that there may be no there there.
https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v...
Apparently most or all of the studies do not include zinc. Hooray.
Again, there may actually be a study which says what you've claimed. I'm not anti-HCQ, I'm anti-propaganda-posing-as-science.
EDIT: And to be clear the Indian studies suggested you wanted to be taking it for weeks before first exposure to SARS-2.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/00...
Just because something is a useful medicine that's been given for a while doesn't mean it can't also have serious side effects, some of which could conceivably exacerbate Sars-CoV-2.
Or not, there's no evidence that it does. But a lot of medicines are "dangerous", including Plaquenil, particularly if applied for the wrong circumstance or given to people with contraindications.
The reverse, there's confirmation it's ineffective. It may not be dangerous (I don't know) but it's no longer allowed as treatment in the US as the evidence has shown it's not useful.
Can we stop talking about this and move on yet? It was only ever really of interest because Trump was flailing about for anything to make it look like he had a plan earlier in the year.
Couldn't agree more. It's insane that medical science gets turned into a partisan pissing match.
This seems to have been going on since Wakefield and the anti-vaxers; and one of the big reasons for rejecting chloroquine was exactly that it was being promoted by a whole infrastructure of dodgy quack websites. Which is undoubtedly where Trump got the idea from.
This is not true. It is still allowed as a treatment, and there are still studies going on using it in the US. The FDA emergency approval has been removed, which is more of a technical status. You can no longer acquire it from the government stockpile, and it is no longer recommended.
Regardless, the point stands, evidence of efficacy is lacking, evidence of lack of efficacy appears to be coming in, this whole thing has turned into a political canard and is likely distracting from real progress.
All the early studies that indicated some effectiveness were basically garbage. The french study that caused most hype was flawed in multiple ways. The fact that a study showing its ineffectiveness was retracted is not evidence of the opposite.
AFAIK, at this point we can't tell if it has a very tiny positive effect or a small damaging one. None are good news, so why push it further?
But I would guess that the survival rate for patients who don't require oxygen must be pretty damn high to start with.
> Among the patients who received usual care alone, 28-day mortality was highest in those who required ventilation (41%), intermediate in those patients who required oxygen only (25%), and lowest among those who did not require any respiratory intervention (13%).
https://www.sciencedaily.com/releases/2020/05/200513081810.h...
https://en.wikipedia.org/wiki/Disseminated_intravascular_coa...
https://emcrit.org/ibcc/covid19/#disseminated_intravascular_...
- low dose of blood thinner (also significant improvement and widely available)
- IL-6 inhibitor tocilizumab (some improvement in severe cases but expensive and hard to scale up)
Both dexamethasone and tocilizumab weaken the immune system. Helps against the overshooting but risks other infections.
I have a particular interest in this because of Crohn's Disease - might the disease be making me high risk, and might my treatment (Entyvio, which operates differently from Remicade and its kin) help offset that anyway?
This looks like a technical phrase, and the parenthesis suggests that its meaning or implications should maybe be obvious, but they aren't to me! Do you mind elaborating?
As you can imagine, it is quite variable in what it means, because it varies across countries and occasionally even hospitals (I'm sure the RECOVERY people have taken this into account, though).
It is different from a placebo study because in that case your control is something you know is inert and "does nothing".